TABLE 3.
Allergy practical considerations and general management during COVID‐19 pandemic in allergic rhinitis patients (Q15, Q18)
| n = 309 responses | % | |
|---|---|---|
| Q15. Have you changed your prescriptions of intranasal corticosteroids in patients with allergic rhinitis? | ||
| Yes, I increased the prescriptions | 18 | 5.83 |
| Yes, I reduced the prescriptions | 5 | 1.62 |
| I did not change my prescription patterns | 278 | 89.97 |
| I do not know | 8 | 2.59 |
| n = 309 responses | % | |
|---|---|---|
| Q18. If there is a suspicion of COVID‐19 infection, do you continue intranasal steroids at the same dose in rhinitis patients? | ||
| Yes, I continued same dose | 258 | 83.50 |
| I decrease the dose to two third | 1 | 0.32 |
| I decrease the dose to half | 4 | 1.29 |
| I stop intranasal steroids | 23 | 7.44 |
| I do not know | 23 | 7.44 |
Abbreviation: COVID‐19, Coronavirus disease 2019.